Issue 15, 2023
From the journal:

Nanoscale Advances

Correction: Optimization and characterization of miRNA-129-5p-encapsulated poly (lactic-co-glycolic acid) nanoparticles to reprogram activated microglia

Irina Kalashnikova,a   Heather R. Campbell,a   Daniel Kolpeka  and  Jonghyuck Park*ab  

* Corresponding authors

a Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 S. Limestone, Lexington, KY 40506, USA
E-mail: jonghyuck.park@uky.edu
Tel: +1-859-257-1850

b Spinal Cord and Brain Injury Research Center, College of Medicine, University of Kentucky, Lexington, KY, USA

Abstract

Correction for ‘Optimization and characterization of miRNA-129-5p-encapsulated poly (lactic-co-glycolic acid) nanoparticles to reprogram activated microglia’ by Irina Kalashnikova, et al., Nanoscale Adv., 2023, https://doi.org/10.1039/D3NA00149K.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D3NA90065G
Article type
Correction
Submitted
19 Jun 2023
Accepted
19 Jun 2023
First published
04 Jul 2023
This article is Open Access
Creative Commons BY license

Nanoscale Adv., 2023,5, 4002-4002

Permissions

Request permissions

Correction: Optimization and characterization of miRNA-129-5p-encapsulated poly (lactic-co-glycolic acid) nanoparticles to reprogram activated microglia

I. Kalashnikova, H. R. Campbell, D. Kolpek and J. Park, Nanoscale Adv., 2023, 5, 4002 DOI: 10.1039/D3NA90065G

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements